Matterhorn Capital Management’s Novartis NVS Stock Holding History

Matterhorn Capital Management’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	$584K	Sell	8,254 -5,341	-39%	-$389K	0.39%	52
2016 Q2	$1M	Sell	13,595 -9,974	-42%	-$689K	0.64%	43
2016 Q1	$1.53M	Sell	23,569 -16,542	-41%	-$1.13M	0.99%	49
2015 Q4	$3.09M	Sell	40,111 -16	-0%	-$1.27K	1.41%	41
2015 Q3	$3.31M	Buy	40,127 +101	+0.3%	+$8.99K	1.59%	30
2015 Q2	$3.53M	Sell	40,026 -1,917	-5%	-$176K	1.51%	32
2015 Q1	$3.71M	Sell	41,943 -1,550	-4%	-$137K	1.65%	29
2014 Q4	$3.61M	Buy	43,493 +494	+1%	+$40.9K	1.69%	29
2014 Q3	$3.63M	Buy	42,999 +583	+1%	+$47.2K	1.62%	27
2014 Q2	$3.44M	Sell	42,416 -4,176	-9%	-$328K	1.53%	32
2014 Q1	$3.41M	Sell	46,592 -444	-0.9%	-$32.4K	1.57%	36
2013 Q4	$3.39M	Sell	47,036 -19	-0%	-$1.32K	1.56%	36
2013 Q3	$3.23M	Buy	47,055 +1,032	+2%	+$68.3K	1.62%	33
2013 Q2	$2.92M	Buy	+46,023	New	+$2.99M	1.61%	33

Other funds holding NVS

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

BBHC

Brown Brothers Harriman & Co New York $22.8B AUM 25.09% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return

Matterhorn Capital Management's NVS Position: Q3 2016 in Review

Matterhorn Capital Management reduced its Novartis (NVS) stake by 39% in Q3 2016, selling an estimated $389K and leaving 8,254 shares worth $584K. The position accounts for 0.39% of the portfolio, ranked #52.

Matterhorn Capital Management first reported a position in NVS in Q2 2013 and has held it in 14 quarters since. The position peaked at $3.71M in Q1 2015. 877 funds tracked by Wall St. Rank hold NVS as of Q3 2016.

Matterhorn Capital Management held 8,254 shares of Novartis worth $584K as of Q3 2016.
Matterhorn Capital Management sold 5,341 Novartis shares in Q3 2016, an estimated $389K.
Novartis made up 0.39% of Matterhorn Capital Management's portfolio in Q3 2016, its #52 holding.
Matterhorn Capital Management first reported a position in Novartis in Q2 2013 and has held it in 14 quarters since.
Matterhorn Capital Management's Novartis position peaked at $3.71M in Q1 2015.
877 funds tracked by Wall St. Rank held Novartis as of Q3 2016.

Based on Matterhorn Capital Management's 13F filing for Q3 2016, filed 10 Nov 2016.